Binitio Biomedical’s Exia 160 and Exia 160XL now Available Through MediLumine

One challenge for development of non toxic micro-CT contrast agents is to load a high concentration of an X-ray attenuating element in a nanoparticulate formulation with particle size distribution small enough to avoid accumulation in lungs but large enough to avoid kidney filtration.  Binitio Biomedical’s Exia 160 and Exia 160XL meet these requirements with sufficient stealth properties for vascular imaging. In addition, they are made of components which are metabolized by catabolic pathways in the body thus enabling metabolic imaging of the myocardium and brown adipose tissue.

Share This Post

More To Explore

Schedule a Live Demo of LightTrack OiS200

Get answers to your questions about LightTrack OiS200 by booking a virtual demo. The demo will allow you to qualify LightTrack OiS200 for your specific application and get answers to

LightTrack OiS 200 In Vivo Imaging System

MediLumine has partnered with Labeo Technologies Inc. for distribution and applications development of the LightTrack OiS200 modular in vivo imaging system for speckle, fluorescence, and intrinsic

Managed by Carbon Digital